SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
New Stock Indexes to Track Trends in Healthcare Sector
STEM
|
|
|
-20.42%
in
13 days
Coming Soon. . . a premium service offered in collaboration with Investars YOU for full access to a global database of over 1,000 stocks which are organized and managed within my 20 ProActive HavRx stock indexes . The expected pricing for premium access is $60 per year and will include full access to all of the component stocks in the indexes and tracking data for the indexes. <> Emerging Cancer Diagnostic / Therapeutic (Dx / Tx) Index
The actively managed HavRx Emerging Cancer Dx / Tx Index constituents reflect a cross-section of emerging cancer companies with <><><><><><><><><><><><><><><><><><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< /><><><><><><><><><><>< />< /><><>< />< />< />< /><><>< />< /><><>< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< />< />< /><><>< />< /><><><><><><><><><>...
|
Bullish on STEM ...
STEM
|
|
|
+0.00%
in
4 minutes
(closed on 10/20/09)
Stem cell transplants stalled blindness in rats ...The findings raise hope for use of the treatment in humans with a range of diseases in which the retina become damaged, including age-related macular degeneration or AMD, which affects nearly 30 million people worldwide, including 15 million Americans... http://www.reuters.com/article/companyNews/idUKTRE59I6G120091...
|
Stem Cell Index Surges in Past Week
STEM
|
|
|
-16.47%
in
171 days
(closed on 10/28/09)
<> The stem cell trade was back in a big way over the past week, with several stocks in the <font> ETF Innovators Stem Cell Index </font> registering impressive gains, compared to market and biotech ETF benchmarks such as the S&P 500 SPDR (NYSE:SPY) +6%, iShares Nasdaq Biotech (NASDAQ:IBB) +2%, SPDR S&P Biotech (NYSE:XBI +4%). Hot stocks over the past week among the 40 component companies in the stem cell index include NeoStem (AMEX:NBS) +52.2%, Cytori Therapeutics (NASDAQ:CYTX) +37%, and Geron (NASDAQ:GERN) +22%. Two other widely followed stocks from the index registered smaller gains,...
|
Stem Cell Index: YTD Analysis, Banking on NeoStem
STEM
|
|
|
+5.59%
in
29 days
(closed on 05/10/09)
<> <> <> <!-- <td valign="top" width="1%"> <img src="/images/quotes.gif" /> </td> --> <> <> Related Tickers: NBS, IART, OSIR, STEM, GE, XLV, IBB, XBI, PBE, SPY Disclosure: No Positions <> The ETF Innovators Global Stem Cell and Regenerative Medicine Index tracks the performance of 40 stem cell and regenerative medicine companies on a globa...
|
Stem Cell Index Soars on Lift of Funding Ban
STEM
|
|
|
+18.27%
in
32 days
(closed on 04/11/09)
|
From the Blogosphere
Shares of Stem Cells (STEM) Rally on Obama news
Shares of StemCells, Inc. (Public, NASDAQ:STEM) are up 43% today - we told you it was  coming in our article titled Obama puts the smack down on Stem Cell law back in February.
Here's the story:
Â
Pledging that his administration will “make scientific decisions based on facts, not ideology,†President Obama on Monday lifted the Bush administration’s strict limits on human embryonic stem cell research.
read more
|
Stem Cell Stocks Update
|
|
|
Today, Monday, March 9, President Barack Obama will be signing an executive order to eliminate a ban on federal funding for embryonic stem-cell research. This major change in policy will cause the research into stem cell therapy to increase substantially. Research has been continuing to utilize stem cells for gene therapy and the treatment of Parkinson’s disease, heart disease, diabetes, multiple sclerosis, arthritis, and many other medical conditions.
Stem cells can come from embryos and from cord blood, the blood from umbilical cords, and even in baby teeth.
Alexion Pharmaceuticals...
|
Analysis of Stem Cell Index YTD
|
|
|
The accompanying table includes statistics for the 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which is down 13.8% at a value of 3,387 from a 2/22/09 inception date value of 3,928.
The index is down 30.6% over the past year on an equal-weight basis, compared to losses of 31.2% for the Healthcare Sector SPDR (XLV), 19% for iShares Nasdaq Biotech (IBB), 14.7% for SPDR S&P Biotech (XBI), 29.7% for PowerShares Biotech & Genome (PBE), and 46.1% for the S&P 500 SPDR (SPY).
Below is a profile for each company, including a summary of their business and researc...
|
Stem Cell Stocks Soar After Hours
|
|
|
Shares of many companies included in the ETF Innovators Global Stem Cell & Regenerative Medicine and Cosmetic & Restorative Medicine Indexes are soaring after-hours today on word President Obama will lift the federal funding ban on stem cell research. Please be careful if you are chasing these stocks AH as the liquidity and trading volumes may dry up quickly since it is a Friday evening and the percentage moves are massive to the upside. <>
Stem Cells (STEM) +50%, Geron (GERN) +37%, Cytori Therapeutics (CYTX) +30%, ThermoGenesis (KOOL) +27%, and Osiris Therapeutics (OSIR) +14% provide a sample...
|
Global Stem Cell and Regenerative Medicine Index
|
|
|
The accompanying table (click to enlarge) includes 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which represents an expansion of the Emerging Stem Cell Index I have written about previously. The expanded global index includes companies with market caps less than $1B at the index inception with a total market value of $3,814 as of the close today. As previously, I will track the total market value for a more comprehensive gauge of investor sentiment toward the space.
The index is down 16.2% over the past year on an equal-weight basis, compared to losses...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on STEM |
Visit streetinsider.com
|
|
|
|
sam1933
(-5.56% risk: conservative)
|
|
|
EMGE-Stem Cell Play
- I think the significance of this Press Release has been overlooked, and hope the company has more plans to explain its story:
Emergent Health Corp. (E...
|
More Resources
|
About StemCells Inc.
- Answers.com
